Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,709Revenue (TTM) $M1,541Net Margin (%)26.2Altman Z-Score3.0
Enterprise Value $M10,062EPS (TTM) $6.6Operating Margin %39.1Piotroski F-Score6
P/E(ttm)22.1Beneish M-Score-2.5Pre-tax Margin (%)34.1Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales5.85-y EBITDA Growth Rate %28.9Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow15.4y-y EBITDA Growth Rate %15.1ROA % (ttm)8.9Higher Current Ratio y-yN
Dividend Yield %--PEG0.8ROE % (ttm)21.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M60.1ROIC % (ttm)14.4Gross Margin Increase y-yN

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

JAZZ is held by these investors:



JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COZADD BRUCE CChairman & CEO 2017-10-02Sell1,000$150-3.33view
COZADD BRUCE CChairman & CEO 2017-09-12Sell1,000$153.52-5.55view
ENRIGHT PATRICK GDirector 2017-08-25Sell351$148.4-2.29view
MILLER MICHAEL PATRICKEVP, US Commercial 2017-08-15Sell200$144.380.43view
Treacy PaulSVP, Technical Operations 2017-08-14Sell1,304$143.321.17view
Winningham Rick EDirector 2017-08-11Sell662$142.371.85view
Sohn Catherine A.Director 2017-08-11Sell662$142.371.85view
Schnee ElmarDirector 2017-08-11Sell1,199$142.371.85view
RIEDEL NORBERT GDirector 2017-08-11Sell662$142.371.85view
O'Keefe Kenneth WDirector 2017-08-11Sell662$142.371.85view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
5 Health Care Companies in Gurus' Portfolios Oct 16 2017 
Andreas Halvorsen Scoops Up Abeona Therapeutics Oct 03 2017 
Fortune Magazine Names Jazz Pharmaceuticals 78th Fastest Growing Company for 2017 Sep 12 2017 
Jazz Pharmaceuticals Announces Completion of Offering and Exercise in Full of Initial Purchasers' Op Sep 01 2017 
Jazz Pharmaceuticals to Present at the Wells Fargo Securities Healthcare Conference Aug 30 2017 
Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Aug 29 2017 
Jazz Pharmaceuticals Announces Offering of $500 Million of 1.50% Exchangeable Senior Notes due 2024 Aug 18 2017 
Jazz Pharmaceuticals Announces Offering of $500 Million of Exchangeable Senior Notes due 2024 Aug 17 2017 
Jazz Pharmaceuticals Announces Webcast for Vyxeos Investor Update Aug 03 2017 
Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome for Aug 03 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK